Former group members

Johanne U. Hermansen, PhD student (University of Oslo/KG Jebsen Centre for B-cell Malignancies)

Mathilde Le Riguier, Master's student (Aix Marseille Université)

Johanna Elvira Haarstad, Master's student (Norwegian University of Life Sciences, NMBU)

Aleksandra Urban, PostDoc (Horizon 2020/ERA PerMed)

Evangelia Maria Salampasi, Erasmus student (University of Oslo)

Eva Rebecca Svanberg Teglgaard, PhD internship (University Hospital of Copenhagen)

Linda Karlsen, MD/PhD student (University of Oslo)

Katrine Melvold, Master's student (University of Oslo)

Henrik Bendiksen, Master's student (University of Bergen)

Johanne U. Hermansen, Master's student (Norwegian University of Life Sciences, NMBU)

Ida K. Myhrvold, Master's student (Norwegian University of Life Sciences, NMBU)

Scroll to top

Recent publications

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K (2025)
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
iScience, 28 (3), 111931
DOI 10.1016/j.isci.2025.111931, PubMed 40034859

Arseni L, Sigismondo G, Yazdanparast H, Hermansen JU, Mack N, Ohl S, Kalter V, Iskar M, Kalxdorf M, Friedel D, Rettel M, Paul Y, Ringshausen I, Eldering E, Dubois J, Kater AP, Zapatka M, Roessner PM, Tausch E, Stilgenbauer S, Dietrich S, Savitski MM, Skånland SS, Krijgsveld J, Lichter P et al. (2025)
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL
Nat Commun, 16 (1), 1041
DOI 10.1038/s41467-025-56318-7, PubMed 39863584